Xsensio develops Lab-on-Skin technology for next-generation wearables that enable real-time biochemical sensing for healthcare applications.
Xsensio has raised $7.0M in total funding. The most recent round was Series A. The last funding was announced in March 2026.
Xsensio's investors include European Innovation Council, Venture Kick, WI Harper Group, Privilège Ventures, Propel(X).
Xsensio is headquartered in Lausanne, Switzerland.
Xsensio develops Lab-on-Skin technology for next-generation wearables that enable real-time biochemical sensing for healthcare applications.
Xsensio is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Xsensio — Funding & Investors." VCBacked, March 2, 2026, https://www.vcbacked.co/company/xsensio. Accessed July 19, 2026.
VCBacked. (2026). Xsensio — Funding & Investors. Retrieved July 19, 2026, from https://www.vcbacked.co/company/xsensio
{{cite web |title=Xsensio — Funding & Investors |url=https://www.vcbacked.co/company/xsensio |website=VCBacked |access-date=July 19, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated